Boothbay Fund Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,737
Closed -$790K 2216
2025
Q4
$790K Sell
7,737
-3,927
-34% -$351K 0.01% 905
2025
Q3
$729K Buy
+11,664
New +$635K 0.01% 976
2024
Q2
Sell
-100,000
Closed -$2.33M 1656
2024
Q1
$2.06M Buy
+100,000
New +$2.14M 0.04% 495
2023
Q3
Sell
-25,776
Closed -$923K 1860
2023
Q2
$923K Buy
+25,776
New +$740K 0.02% 865

Other funds holding GH

Boothbay Fund Management's GH Position: Q1 2026 in Review

Boothbay Fund Management sold out of Guardant Health (GH) in Q1 2026, closing a stake of 7,737 shares — an estimated $790K sold.

Boothbay Fund Management first reported a position in GH in Q2 2023 and held it in 4 quarters. The position peaked at $2.06M in Q1 2024. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Boothbay Fund Management reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 7,737 Guardant Health shares in Q1 2026, an estimated $790K.
  • Boothbay Fund Management first reported a position in Guardant Health in Q2 2023 and held it in 4 quarters.
  • Boothbay Fund Management's Guardant Health position peaked at $2.06M in Q1 2024.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.